biological drug


Also found in: Medical.

biological drug

n.
Mentioned in ?
References in periodicals archive ?
clinical development plan for EscharEx, the Company's topical biological drug candidate for the debridement of chronic and hard-to-heal wounds.
One of the biotech innovators was Eisai Co., which exemplified the trend of pharmaceutical companies purchasing biological drug makers as a way to expand their pipelines.
Her study included 1,062 PsA patients enrolled during December 2013-December 2014 in the Danish DANBIO registry of patients with inflammatory arthritides who received treatment with a biological drug. These participants also agreed both to complete a painDETECT Questionnaire and to rate their fatigue on a visual analog scale.
"Being a biological drug, it has a totally different philosophy and its benefits, once in the market, will go to patients beyond Bahrain.
Food and Drug Administration approval of a biological drug for the treatment of a certain form of lung cancer.
Jean-Marc Nabholtz, director of cancer research at King Saud University in Riyadh, said that a new biological drug, Denosumab, which is given under the skin monthly, shows positive results and reduces the need for radiation and surgical intervention.
Therefore, we stopped methotrexate therapy, and changed the treatment with biological drug. Etanercept (25 mg/week) with steroids (5 mg/day) therapy was started in 2012.
SAFC Commercial, the custom manufacturing services business unit of Sigma-Aldrich Corp., has introduced a new protein quality supplement called EX-CELL Glycosylation Adjust (Gal+), designed as a supplement for biological drug production, including biosimiliars.
Humira is a biological drug approved by the Food and Drug Administration in 2002 as a treatment for rheumatoid arthritis, an autoimmune disease in which the body turns on itself and sets off painful disfigurement of the joints.
TiGenix is working with a group of clinical experts, including Luyten, to complete the protocol for a randomized, double-blind, comparative Phase 2 study to test the efficacy of Cx611 in patients exhibiting substantial disease activity of rheumatoid arthritis despite treatment with methotrexate and corticosteroids, but unexposed to a biological drug.
Biological drug products; development and strategies.
All patients are tested for LTBI before starting a biological drug and are treated if the infection is present.

Full browser ?